Medscape2d
Does COVID-19 Vaccination Affect Thyroid Health Long Term?
COVID-19 vaccination is linked to a transient decrease in hyperthyroidism risk but an increase in hypothyroidism risk over 12 ...
Yahoo Finance6d
NervGen Completes Dosing of First Subject in Subacute Cohort of its Phase 1b/2a Clinical Trial of NVG-291 in Spinal Cord Injury
NervGen Completes Dosing of First Subject in Subacute Cohort of its Phase 1b/2a Clinical Trial of NVG-291 in Spinal Cord Injury Newsfile Corp. Thu, Feb 6, 2025, 4:30 AM 7 min read ...
The Globe and Mail6d
NervGen Completes Dosing of First Subject in Subacute Cohort of its Phase 1b/2a Clinical Trial of NVG-291 in Spinal Cord Injury
Recently, the company received IRB approval for an amendment focused on the subacute cohort of its Phase 1b/2a clinical trial. Key changes to the protocol were implemented to facilitate enrollment ...
Space.com1d
What is the moon phase today? Lunar phases 2025
What is the moon phase today? Today, Feb. 11, 2025, the moon is 13 days old, and approaching the Full Moon phase of its lunar cycle. It is 98% illuminated. Moon phases reveal the passage of time ...
CBS News6d
Colombian Navy intercepts first "narco sub" of year, seizes more than 5,000 pounds of cocaine
A semi-submersible vessel loaded with over 5,000 pounds of cocaine was intercepted off the Pacific coast of Colombia, the country's navy said Wednesday. Officials said it marked the nation's first ...
ABC News5d
Middle East updates: Talks start on 2nd phase of Gaza ceasefire
Israeli Prime Minister Benjamin Netanyahu is in Washington, D.C., as negotiations between Israel and Hamas are expected to continue amid the first phase of the deal, which was slated to last about ...
Yahoo Finance5d
Cyclo Therapeutics Presents Positive Preliminary Data from Ongoing Phase 3 TransportNPC™ Open-Label Sub-Study in Patients (< 3 Years Old)
Clearance of lipids centrally and systemically were consistently demonstrated in a completed 14-week Phase 1 study in adult patients with NPC; At baseline, sub-study patients had a mixture of very ...
Business Wire5d
Cyclo Therapeutics Presents Positive Preliminary Data from Ongoing Phase 3 TransportNPC™ Open-Label Sub-Study in Patients (< 3 Years Old)
For more information about the Company’s TransportNPC™ pivotal Phase 3 study, visit www.ClinicalTrials.gov and reference identifier NCT04860960. Cyclo Therapeutics received Orphan Drug Designa ...
Nasdaq5d
Cyclo Therapeutics Presents Positive Data From Phase 3 NPC1 Sub-Study
(RTTNews) - Cyclo Therapeutics, Inc. (CYTH) on Friday announced promising preliminary data from its ongoing Phase 3 TransportNPC study, evaluating Trappsol Cyclo for the treatment of Niemann-Pick ...
Astronomy2d
2025 Full Moon calendar: When to see the Full Moon and phases
That creates different lunar phases. The next Full Moon will be the Snow Moon, which occurs at 8:53 a.m. on Wednesday, Feb. 12, 2025. We’ll update this article multiple times each week with the ...
Health.com3d
11 Celebrities Who Have Open About Their Thyroid Disorders
Steffini Stalos, DO, FCAP, is a pathology and lab medicine physician. She is also the chief medical officer of the lab consultancy firm Blood Associates, LLC. Many people have experience with ...
BioSpace6d
NervGen Completes Dosing of First Subject in Subacute Cohort of its Phase 1b/2a Clinical Trial of NVG-291 in Spinal Cord Injury
Recently, the company received IRB approval for an amendment focused on the subacute cohort of its Phase 1b/2a clinical trial. Key changes to the protocol were implemented to facilitate enrollment, ...